Project Number 4UH3NS113776-02 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Small Molecule Mitochondria-Targeted Therapeutics for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator TRUSHINA, EUGENIA Principal Investigator First Name EUGENIA Principal Investigator Last Name TRUSHINA Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-546: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional FY Overall Cost $778,431 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CYWIN, CHARLES
